Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Jun 10, 2006

New study shows an innovative mealtime insulin dosing algorithm may provide a safe and effective alternative to carbohydrate counting for patients with type 2 diabetes

Type 2 Diabetes Patients Using a New Insulin Dosing Strategy Achieved a Mean A1C of 6.6% after 24 Weeks of Combination Therapy with Rapid-Acting Apidra(R)
Jun 6, 2006

Studies Evaluating Eloxatin®-Based Regimens in Gastrointestinal Cancers Presented at the 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Jun 3, 2006

Results of a meta-analysis show benefits of TAXOTERE® (docetaxel) regimens in patients with advanced non-small cell lung cancer (NSCLC)

Findings show demonstrated overall survival with less febrile neutropenia for Taxotere(R) versus vinca-alkaloid regimens
Jun 3, 2006

New Phase III data reports on the safety and efficacy of Risedronate for the treatment of male osteoporosis
Jun 1, 2006

Sanofi-aventis General Meeting of Shareholders

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.